{"count": 41, "results": [{"_id": "31778746", "pmid": 31778746, "title": "The right place for metformin today.", "journal": "Diabetes Res Clin Pract", "authors": ["Schernthaner G", "Schernthaner GH"], "date": "2020-01-01T00:00:00Z", "doi": "10.1016/j.diabres.2019.107946", "meta_date_publication": "2020 Jan", "meta_volume": "159", "meta_issue": "", "meta_pages": "107946", "score": 50259.37, "text_hl": "Although a randomized placebo controlled CVOT with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is lacking, many observational studies in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary heart disease@@@, @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@ and @DISEASE_Renal_Insufficiency_Chronic @DISEASE_MESH:D051436 @@@chronic kidney disease@@@ have demonstrated consistent beneficial effects. ", "citations": {"NLM": "Schernthaner G, Schernthaner GH. The right place for metformin today. Diabetes Res Clin Pract. 2020 Jan;159():107946. PMID: 31778746", "BibTeX": "@article{31778746, title={The right place for metformin today.}, author={Schernthaner G and Schernthaner GH}, journal={Diabetes Res Clin Pract}, volume={159}, pages={107946}}"}}, {"_id": "37223024", "pmid": 37223024, "pmcid": "PMC10200869", "title": "The relationship between polycystic ovary syndrome and coronary heart disease: a bibliometric analysis", "journal": "Front Endocrinol (Lausanne)", "authors": ["Liang X", "He H", "Zeng H", "Wei L", "Yang J", "Wen Y", "Fan S", "Fan J"], "date": "2023-05-08T00:00:00Z", "doi": "10.3389/fendo.2023.1172750", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1172750", "score": 50254.562, "text_hl": "As for the fifth cluster, we concluded the potential positive effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on reducing @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@CHD@@@ risk factors in @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Liang X, He H, Zeng H, Wei L, Yang J, Wen Y, Fan S, Fan J. The relationship between polycystic ovary syndrome and coronary heart disease: a bibliometric analysis Front Endocrinol (Lausanne). 2023;14():1172750. PMID: 37223024", "BibTeX": "@article{37223024, title={The relationship between polycystic ovary syndrome and coronary heart disease: a bibliometric analysis}, author={Liang X and He H and Zeng H and Wei L and Yang J and Wen Y and Fan S and Fan J}, journal={Front Endocrinol (Lausanne)}, volume={14}, pages={1172750}}"}}, {"_id": "32342619", "pmid": 32342619, "title": "Effect of metformin on cardiovascular risk factors in middle-aged Thai women with metabolic syndrome: A randomized placebo-controlled trial.", "journal": "J Obstet Gynaecol Res", "authors": ["Indhavivadhana S", "Rattanachaiyanont M", "Wongwananurak T", "Techatraisak K", "Jirattigalachote A", "Dangrat C"], "date": "2020-07-01T00:00:00Z", "doi": "10.1111/jog.14263", "meta_date_publication": "2020 Jul", "meta_volume": "46", "meta_issue": "7", "meta_pages": "1193-1202", "score": 50243.29, "text_hl": "The significant improvements found only in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group were body mass index, fasting blood @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@, high-sensitivity @GENE_CRP @GENE_1401 @@@C-reactive protein@@@ and 10-year risk of @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary heart disease@@@ (Framingham heart study) (P = 0.0004, P = 0.049, P = 0.035 and P = 0.029); whereas that only in the placebo group was high density lipoprotein cholesterol. ", "citations": {"NLM": "Indhavivadhana S, Rattanachaiyanont M, Wongwananurak T, Techatraisak K, Jirattigalachote A, Dangrat C. Effect of metformin on cardiovascular risk factors in middle-aged Thai women with metabolic syndrome: A randomized placebo-controlled trial. J Obstet Gynaecol Res. 2020 Jul;46(7):1193-1202. PMID: 32342619", "BibTeX": "@article{32342619, title={Effect of metformin on cardiovascular risk factors in middle-aged Thai women with metabolic syndrome: A randomized placebo-controlled trial.}, author={Indhavivadhana S and Rattanachaiyanont M and Wongwananurak T and Techatraisak K and Jirattigalachote A and Dangrat C}, journal={J Obstet Gynaecol Res}, volume={46}, number={7}, pages={1193-1202}}"}}, {"_id": "35112779", "pmid": 35112779, "pmcid": "PMC9314577", "title": "Efficacy and safety of alogliptin versus acarbose in Chinese type 2 diabetes patients with high cardiovascular risk or coronary heart disease treated with aspirin and inadequately controlled with metformin monotherapy or drug-naive: A multicentre, randomized, open-label, prospective study (ACADEMIC)", "journal": "Diabetes Obes Metab", "authors": ["Gao B", "Gao W", "Wan H", "Xu F", "Zhou R", "Zhang X", "Ji Q"], "date": "2022-06-01T00:00:00Z", "doi": "10.1111/dom.14661", "meta_date_publication": "2022 Jun", "meta_volume": "24", "meta_issue": "6", "meta_pages": "991-999", "score": 50233.547, "text_hl": "Efficacy and safety of @CHEMICAL_alogliptin @CHEMICAL_MESH:C520853 @@@alogliptin@@@ versus @CHEMICAL_Acarbose @CHEMICAL_MESH:D020909 @@@acarbose@@@ in Chinese @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ @SPECIES_9606 @@@patients@@@ with high cardiovascular risk or @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary heart disease@@@ treated with @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@aspirin@@@ and inadequately controlled with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ monotherapy or drug-naive: A multicentre, randomized, open-label, prospective study (ACADEMIC)", "citations": {"NLM": "Gao B, Gao W, Wan H, Xu F, Zhou R, Zhang X, Ji Q. Efficacy and safety of alogliptin versus acarbose in Chinese type 2 diabetes patients with high cardiovascular risk or coronary heart disease treated with aspirin and inadequately controlled with metformin monotherapy or drug-naive: A multicentre, randomized, open-label, prospective study (ACADEMIC) Diabetes Obes Metab. 2022 Jun;24(6):991-999. PMID: 35112779", "BibTeX": "@article{35112779, title={Efficacy and safety of alogliptin versus acarbose in Chinese type 2 diabetes patients with high cardiovascular risk or coronary heart disease treated with aspirin and inadequately controlled with metformin monotherapy or drug-naive: A multicentre, randomized, open-label, prospective study (ACADEMIC)}, author={Gao B and Gao W and Wan H and Xu F and Zhou R and Zhang X and Ji Q}, journal={Diabetes Obes Metab}, volume={24}, number={6}, pages={991-999}}"}}, {"_id": "35059270", "pmid": 35059270, "title": "Acute esophageal necrosis complicating diabetic ketoacidosis in a patient with type II diabetes mellitus and excessive cola consumption: a case report.", "journal": "Diabetol Int", "authors": ["Avramidou D", "Violatzi P", "Zikoudi DG", "Mourseloglou A", "Panagaris S", "Metaxa E", "Partsalidis A", "Feresiadis I", "Savva C", "Papadopoulos V"], "date": "2021-08-27T00:00:00Z", "doi": "10.1007/s13340-021-00537-y", "meta_date_publication": "2022 Jan", "meta_volume": "13", "meta_issue": "1", "meta_pages": "315-319", "score": 50227.434, "text_hl": "The @SPECIES_9606 @@@patient@@@ had a record of @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ and @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary heart disease@@@, and he was administered @CHEMICAL_empagliflozin @CHEMICAL_MESH:C570240 @@@empagliflozin@@@ 25 mg q24 hours, @CHEMICAL_Vildagliptin @CHEMICAL_MESH:D000077597 @@@vildagliptin@@@ 50 mg bid, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 1000 mg bid, and @CHEMICAL_Insulin_Glargine @CHEMICAL_MESH:D000069036 @@@insulin glargine@@@ 24 IU q 24. ", "citations": {"NLM": "Avramidou D, Violatzi P, Zikoudi DG, Mourseloglou A, Panagaris S, Metaxa E, Partsalidis A, Feresiadis I, Savva C, Papadopoulos V. Acute esophageal necrosis complicating diabetic ketoacidosis in a patient with type II diabetes mellitus and excessive cola consumption: a case report. Diabetol Int. 2022 Jan;13(1):315-319. PMID: 35059270", "BibTeX": "@article{35059270, title={Acute esophageal necrosis complicating diabetic ketoacidosis in a patient with type II diabetes mellitus and excessive cola consumption: a case report.}, author={Avramidou D and Violatzi P and Zikoudi DG and Mourseloglou A and Panagaris S and Metaxa E and Partsalidis A and Feresiadis I and Savva C and Papadopoulos V}, journal={Diabetol Int}, volume={13}, number={1}, pages={315-319}}"}}, {"_id": "7601626", "pmid": 7601626, "title": "[Metformin in patients with coronary disease?].", "journal": "Internist (Berl)", "authors": ["Schneider J"], "date": "1995-05-01T00:00:00Z", "meta_date_publication": "1995 May", "meta_volume": "36", "meta_issue": "5", "meta_pages": "522", "score": 50076.76, "text_hl": "[@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary disease@@@?].", "citations": {"NLM": "Schneider J. [Metformin in patients with coronary disease?]. Internist (Berl). 1995 May;36(5):522. PMID: 7601626", "BibTeX": "@article{7601626, title={[Metformin in patients with coronary disease?].}, author={Schneider J}, journal={Internist (Berl)}, volume={36}, number={5}, pages={522}}"}}, {"_id": "8772621", "pmid": 8772621, "title": "Metformin improves blood lipid pattern in nondiabetic patients with coronary heart disease.", "journal": "J Intern Med", "authors": ["Carlsen SM", "Rossvoll O", "Bjerve KS", "Følling I"], "date": "1996-03-01T00:00:00Z", "doi": "10.1046/j.1365-2796.1996.444790000.x", "meta_date_publication": "1996 Mar", "meta_volume": "239", "meta_issue": "3", "meta_pages": "227-33", "score": 50059.508, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ improves blood @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ pattern in nondiabetic @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary heart disease@@@.", "citations": {"NLM": "Carlsen SM, Rossvoll O, Bjerve KS, Følling I. Metformin improves blood lipid pattern in nondiabetic patients with coronary heart disease. J Intern Med. 1996 Mar;239(3):227-33. PMID: 8772621", "BibTeX": "@article{8772621, title={Metformin improves blood lipid pattern in nondiabetic patients with coronary heart disease.}, author={Carlsen SM and Rossvoll O and Bjerve KS and Følling I}, journal={J Intern Med}, volume={239}, number={3}, pages={227-33}}"}}, {"_id": "8708595", "pmid": 8708595, "title": "Should metformin be used to improve blood lipid pattern in nondiabetic patients with coronary heart disease?", "journal": "J Intern Med", "authors": ["Hoogeveen EK", "Stehouwer CD"], "date": "1996-07-01T00:00:00Z", "meta_date_publication": "1996 Jul", "meta_volume": "240", "meta_issue": "1", "meta_pages": "46-7", "score": 50059.42, "text_hl": "Should @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ be used to improve blood @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ pattern in nondiabetic @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary heart disease@@@?", "citations": {"NLM": "Hoogeveen EK, Stehouwer CD. Should metformin be used to improve blood lipid pattern in nondiabetic patients with coronary heart disease? J Intern Med. 1996 Jul;240(1):46-7. PMID: 8708595", "BibTeX": "@article{8708595, title={Should metformin be used to improve blood lipid pattern in nondiabetic patients with coronary heart disease?}, author={Hoogeveen EK and Stehouwer CD}, journal={J Intern Med}, volume={240}, number={1}, pages={46-7}}"}}, {"_id": "29786570", "pmid": 29786570, "title": "Combination of metformin and pioglitazone and its effect in treatment of comorbid pathology.", "journal": "Wiad Lek", "authors": ["Shaienko ZO", "Bobyreva LY"], "date": "2018-01-01T00:00:00Z", "meta_date_publication": "2018", "meta_volume": "71", "meta_issue": "2 pt 2", "meta_pages": "278-280", "score": 50058.695, "text_hl": "@SPECIES_9606 @@@PATIENTS@@@ AND METHODS: Materials and methods: 95 @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ and @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary heart disease@@@ have been treated and randomized into two groups: the comparison group (n=37), treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylureas@@@, and the study group (n=58), treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in combination with @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@. ", "citations": {"NLM": "Shaienko ZO, Bobyreva LY. Combination of metformin and pioglitazone and its effect in treatment of comorbid pathology. Wiad Lek. 2018;71(2 pt 2):278-280. PMID: 29786570", "BibTeX": "@article{29786570, title={Combination of metformin and pioglitazone and its effect in treatment of comorbid pathology.}, author={Shaienko ZO and Bobyreva LY}, journal={Wiad Lek}, volume={71}, number={2 pt 2}, pages={278-280}}"}}, {"_id": "10516414", "pmid": 10516414, "title": "Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up.", "journal": "Cardiology", "authors": ["Fisman EZ", "Tenenbaum A", "Benderly M", "Goldbourt U", "Behar S", "Motro M"], "date": "1999-01-01T00:00:00Z", "doi": "10.1159/000006909", "meta_date_publication": "1999", "meta_volume": "91", "meta_issue": "3", "meta_pages": "195-202", "score": 50057.625, "text_hl": "Antihyperglycemic treatment in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetics@@@ with @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary disease@@@: increased @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-associated mortality over a 5-year follow-up.", "citations": {"NLM": "Fisman EZ, Tenenbaum A, Benderly M, Goldbourt U, Behar S, Motro M. Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up. Cardiology. 1999;91(3):195-202. PMID: 10516414", "BibTeX": "@article{10516414, title={Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up.}, author={Fisman EZ and Tenenbaum A and Benderly M and Goldbourt U and Behar S and Motro M}, journal={Cardiology}, volume={91}, number={3}, pages={195-202}}"}}]}